Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort.
Postorino MC, Prosperi M, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Saracino A, Costarelli S, Lorenzotti S, Sighinolfi L, Di Pietro M, Torti C; MASTER Study Group. Postorino MC, et al. Clin Microbiol Infect. 2015 Apr;21(4):386.e1-9. doi: 10.1016/j.cmi.2014.10.022. Epub 2014 Nov 11. Clin Microbiol Infect. 2015. PMID: 25595708 Free article.
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study.
Nozza S, Malagoli A, Maia L, Calcagno A, Focà E, De Socio G, Piconi S, Orofino G, Cattelan AM, Celesia BM, Gervasi E, Guaraldi G; GEPPO Study Group. Nozza S, et al. J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169. J Antimicrob Chemother. 2017. PMID: 28605493 Free article.
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
Armenia D, Spagnuolo V, Bellocchi MC, Galli L, Duca L, Marchegiani G, Clemente T, Carioti L, Lolatto R, Calza L, Celesia BM, Cascio A, Francisci D, Saracino A, Torti C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2354-2363. doi: 10.1093/jac/dkae236. J Antimicrob Chemother. 2024. PMID: 39004997
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.
Soria A, Graziano F, Ghilardi G, Lapadula G, Gasperina DD, Benatti SV, Quiros-Roldan E, Milesi M, Bai F, Merli M, Minisci D, Franzetti M, Asperges E, Chiabrando F, Pocaterra D, Pandolfo A, Zanini F, Lombardi D, Cappelletti A, Rugova A, Borghesi ML, Squillace N, Pusterla L, Piconi S, Morelli P, Querini PR, Bruno R, Rusconi S, Casari S, Bandera A, Franzetti F, Travi G, D'Arminio Monforte A, Marchetti G, Pan A, Castelli F, Rizzi M, Dentali F, Mallardo M, Rossi E, Valsecchi MG, Galimberti S, Bonfanti P. Soria A, et al. Among authors: castelli f. Heliyon. 2024 Aug 13;10(16):e36102. doi: 10.1016/j.heliyon.2024.e36102. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39247344 Free PMC article.
868 results